Barclays analyst Julian Mitchell raised the firm’s price target on Emerson (EMR) to $104 from $99 and keeps an Underweight rating on the shares following the earnings report. The company is executing very well operationally, but its end market exposures “will hold the stock back,” the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR:
- Strong Financial Performance and Strategic Decisions Drive Buy Rating for Emerson Electric
- Emerson Electric Reports Strong Q2 2025 Results
- Emerson Electric Reports Strong Q2, Positive Outlook
- Morning Movers: Disney jumps after first quarter earnings, Abu Dhabi resort plan
- Emerson narrows FY25 adjusted EPS view $5.90-$6.05 from $5.85-$6.05